InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
Revenues during 2023 reached NIS 356 million, alongside an Adjusted EBITDA1 of NIS 61 million , as compared to an Adjusted EBITDA of NIS 51 million in our preliminary results. The Company’s...
Source: marketscreener.com